BEAM
Price
$26.45
Change
-$2.13 (-7.45%)
Updated
Dec 18, 04:59 PM (EDT)
76 days until earnings call
KOD
Price
$9.01
Change
+$0.14 (+1.58%)
Updated
Dec 18, 01:41 PM (EDT)
99 days until earnings call
Ad is loading...

BEAM vs KOD

Header iconBEAM vs KOD Comparison
Open Charts BEAM vs KODBanner chart's image
Beam Therapeutics
Price$26.45
Change-$2.13 (-7.45%)
Volume$26.28K
CapitalizationN/A
Kodiak Sciences
Price$9.01
Change+$0.14 (+1.58%)
Volume$200
CapitalizationN/A
BEAM vs KOD Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. KOD commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and KOD is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (BEAM: $28.58 vs. KOD: $8.87)
Brand notoriety: BEAM and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 130% vs. KOD: 91%
Market capitalization -- BEAM: $2.37B vs. KOD: $466.77M
BEAM [@Biotechnology] is valued at $2.37B. KOD’s [@Biotechnology] market capitalization is $466.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileKOD’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • KOD’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and KOD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while KOD’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • KOD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than KOD.

Price Growth

BEAM (@Biotechnology) experienced а -5.36% price change this week, while KOD (@Biotechnology) price change was -11.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.60%. For the same industry, the average monthly price growth was +1.53%, and the average quarterly price growth was +3.09%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

KOD is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-3.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.37B) has a higher market cap than KOD($467M). KOD YTD gains are higher at: 191.776 vs. BEAM (4.996).
BEAMKODBEAM / KOD
Capitalization2.37B467M507%
EBITDAN/AN/A-
Gain YTD4.996191.7763%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
KOD: Fundamental Ratings
KOD
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMKOD
RSI
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.21%
CRSP - BEAM
72%
Closely correlated
+0.88%
NTLA - BEAM
65%
Loosely correlated
-1.87%
DNLI - BEAM
65%
Loosely correlated
-0.30%
PRME - BEAM
62%
Loosely correlated
-3.00%
RXRX - BEAM
61%
Loosely correlated
-4.30%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with AKBA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then AKBA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+9.24%
AKBA - KOD
41%
Loosely correlated
+1.63%
IMNM - KOD
40%
Loosely correlated
-3.38%
MGTX - KOD
39%
Loosely correlated
+1.91%
BEAM - KOD
39%
Loosely correlated
-1.21%
RXRX - KOD
39%
Loosely correlated
-4.30%
More